We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.09B
AUM Growth
-$461M
Cap. Flow
+$404M
Cap. Flow %
13.07%
Top 10 Hldgs %
27.53%
Holding
139
New
26
Increased
37
Reduced
15
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 44.32%
2 Technology 23.01%
3 Industrials 9.93%
4 Consumer Discretionary 5.91%
5 Utilities 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$191M 6.19%
1,698,648
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.64B
$97.4M 3.16%
996,000
FIVN icon
3
FIVE9
FIVN
$2.12B
$93.1M 3.02%
1,218,000
-32,000
-3% -$2.28M
EXAS
4
DELISTED
Exact Sciences
EXAS
$80.7M 2.61%
1,392,000
+897,000
+181% +$72.8M
ZGNX
5
DELISTED
Zogenix, Inc.
ZGNX
$70.3M 2.28%
2,841,300
ROP icon
6
Roper Technologies
ROP
$38.5B
$66.7M 2.16%
214,000
KRTX
7
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$64.9M 2.1%
901,077
+686,234
+319% +$58.7M
WCN
8
Waste Connections
WCN
$41.9B
$62.3M 2.02%
804,000
IGV icon
9
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.5B
$62M 2.01%
+1,455,000
New +$68.8M
TWLO icon
10
Twilio
TWLO
$29B
$61.3M 1.99%
685,000
-142,000
-17% -$15.6M
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$60.7M 1.97%
1,783,761
+149,761
+9% +$6.85M
TTD icon
12
Trade Desk
TTD
$8.59B
$57.9M 1.88%
3,000,000
-1,250,000
-29% -$32.3M
AIMT
13
DELISTED
Aimmune Therapeutics
AIMT
$55.5M 1.8%
3,851,000
+767,000
+25% +$19.6M
CRWD icon
14
CrowdStrike
CRWD
$189B
$55M 1.78%
+3,948,000
New +$55.7M
SPLK
15
DELISTED
Splunk Inc
SPLK
$54M 1.75%
428,000
XIFR
16
XPLR Infrastructure LP
XIFR
$1.12B
$53.4M 1.73%
1,242,800
+176,878
+17% +$9.37M
XYL icon
17
Xylem
XYL
$27.3B
$51.6M 1.67%
793,000
+3,200
+0.4% +$252K
LOW icon
18
Lowe's Companies
LOW
$118B
$51.3M 1.66%
596,600
+6,200
+1% +$677K
DT icon
19
Dynatrace
DT
$12.8B
$49.5M 1.6%
2,076,400
+1,251,500
+152% +$36.1M
MTD icon
20
Mettler-Toledo International
MTD
$27.9B
$49M 1.59%
71,000
-1,610
-2% -$1.2M
LRCX icon
21
Lam Research
LRCX
$372B
$48.2M 1.56%
2,010,000
LII icon
22
Lennox International
LII
$14.5B
$46.4M 1.5%
255,000
+55,000
+28% +$12.7M
ASML icon
23
ASML
ASML
$634B
$45M 1.46%
172,000
-8,900
-5% -$2.53M
HUBS icon
24
HubSpot
HUBS
$11.9B
$44.2M 1.43%
332,000
-18,000
-5% -$2.99M
VMC icon
25
Vulcan Materials
VMC
$35.2B
$43.4M 1.41%
401,700
+82,800
+26% +$10.6M

Similar funds

Eventide Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Eventide Asset Management held 139 positions worth $3.09B, down 13% from $3.55B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $404M of net new capital in Q1 2020, opening 26 new positions and adding to 37 existing holdings. Its largest new stake was CrowdStrike: 3,948,000 shares worth $55M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Myovant Sciences Ltd., an estimated $37.3M trimmed.

  • Eventide Asset Management's largest Q1 2020 buy was CrowdStrike: 3,948,000 shares worth $55M.
  • Eventide Asset Management added most to Exact Sciences in Q1 2020, an estimated $72.8M increase.
  • Eventide Asset Management's biggest Q1 2020 reduction was Myovant Sciences Ltd., cutting an estimated $37.3M.
  • Eventide Asset Management fully exited IAA, Inc. Common Stock in Q1 2020, selling an estimated $28.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $3.09B portfolio in Q1 2020.
  • Eventide Asset Management opened 26 new positions and closed 17 in Q1 2020.
  • Eventide Asset Management's portfolio value fell 13% quarter-over-quarter to $3.09B.

Based on Eventide Asset Management's 13F filing for Q1 2020, filed 15 May 2020.